Infant Bacterial Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Infant Bacterial Therapeutics has a total shareholder equity of SEK277.3M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK348.9M and SEK71.5M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 309.62m |
| Equity | SEK 277.34m |
| Total liabilities | SEK 71.54m |
| Total assets | SEK 348.88m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: IFTB.F's short term assets (SEK339.3M) exceed its short term liabilities (SEK71.5M).
Long Term Liabilities: IFTB.F has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: IFTB.F is debt free.
Reducing Debt: IFTB.F has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: IFTB.F has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: IFTB.F has sufficient cash runway for 2.5 years if free cash flow continues to reduce at historical rates of 17.2% each year.